Inglés

Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.

18 formularios  
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
pht006081
Descripción

pht006081

Alias
UMLS CUI [1,1]
C3846158
De-identified sample ID
Descripción

SAMPLE_ID

Tipo de datos

string

Alias
UMLS CUI [1,1]
C4684638
UMLS CUI [1,2]
C1299222
Body site where sample was collected
Descripción

BODY_SITE

Tipo de datos

string

Alias
UMLS CUI [1,1]
C0449705
Analyte type
Descripción

ANALYTE_TYPE

Tipo de datos

string

Alias
UMLS CUI [1,1]
C4744818
Tumor status
Descripción

IS_TUMOR

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0475752
Cell or tissue type or subtype of sample
Descripción

HISTOLOGICAL_TYPE

Tipo de datos

string

Alias
UMLS CUI [1,1]
C2347026
UMLS CUI [1,2]
C0007634
UMLS CUI [1,3]
C0332307
UMLS CUI [2,1]
C2347026
UMLS CUI [2,2]
C0007634
UMLS CUI [2,3]
C0449560
UMLS CUI [3,1]
C1292533
UMLS CUI [3,2]
C0332307
UMLS CUI [4,1]
C1292533
UMLS CUI [4,2]
C0449560
Primary tumor, metastasis, or transformed cell line
Descripción

PRIMARY_METASTATIC_TUMOR

Tipo de datos

string

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [2,1]
C0027627
UMLS CUI [3,1]
C0007601
Primary tumor location
Descripción

PRIMARY_TUMOR_LOCATION

Tipo de datos

string

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0450429
Tumor stage of sample
Descripción

TUMOR_STAGE

Tipo de datos

string

Alias
UMLS CUI [1,1]
C1300072
Tumor grade of sample
Descripción

TUMOR_GRADE

Tipo de datos

string

Alias
UMLS CUI [1,1]
C0919553
Type of tumor treatment for sample
Descripción

TUMOR_TREATMENT

Tipo de datos

string

Alias
UMLS CUI [1,1]
C0332307
UMLS CUI [1,2]
C0003392
Name of the center which conducted genotyping
Descripción

GENOTYPING_CENTER

Tipo de datos

string

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0565990
UMLS CUI [1,3]
C1285573
Name of the center which conducted sequencing
Descripción

SEQUENCING_CENTER

Tipo de datos

string

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0565990
UMLS CUI [1,3]
C1561491
Volver a la parte superior de la página

Similar models

Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.

18 formularios
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
pht006081
C3846158 (UMLS CUI [1,1])
SAMPLE_ID
Item
De-identified sample ID
string
C4684638 (UMLS CUI [1,1])
C1299222 (UMLS CUI [1,2])
BODY_SITE
Item
Body site where sample was collected
string
C0449705 (UMLS CUI [1,1])
ANALYTE_TYPE
Item
Analyte type
string
C4744818 (UMLS CUI [1,1])
Item
Tumor status
text
C0475752 (UMLS CUI [1,1])
IS_TUMOR
Code List
Tumor status
CL Item
Is not a tumor (N)
CL Item
Is tumor (Y)
HISTOLOGICAL_TYPE
Item
Cell or tissue type or subtype of sample
string
C2347026 (UMLS CUI [1,1])
C0007634 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C2347026 (UMLS CUI [2,1])
C0007634 (UMLS CUI [2,2])
C0449560 (UMLS CUI [2,3])
C1292533 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C1292533 (UMLS CUI [4,1])
C0449560 (UMLS CUI [4,2])
PRIMARY_METASTATIC_TUMOR
Item
Primary tumor, metastasis, or transformed cell line
string
C0677930 (UMLS CUI [1,1])
C0027627 (UMLS CUI [2,1])
C0007601 (UMLS CUI [3,1])
PRIMARY_TUMOR_LOCATION
Item
Primary tumor location
string
C0677930 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
TUMOR_STAGE
Item
Tumor stage of sample
string
C1300072 (UMLS CUI [1,1])
TUMOR_GRADE
Item
Tumor grade of sample
string
C0919553 (UMLS CUI [1,1])
TUMOR_TREATMENT
Item
Type of tumor treatment for sample
string
C0332307 (UMLS CUI [1,1])
C0003392 (UMLS CUI [1,2])
GENOTYPING_CENTER
Item
Name of the center which conducted genotyping
string
C1301943 (UMLS CUI [1,1])
C0565990 (UMLS CUI [1,2])
C1285573 (UMLS CUI [1,3])
SEQUENCING_CENTER
Item
Name of the center which conducted sequencing
string
C1301943 (UMLS CUI [1,1])
C0565990 (UMLS CUI [1,2])
C1561491 (UMLS CUI [1,3])
Volver a la parte superior de la página